I’m confused
Our DMD trial is in Europe
So we need the ok from the European authorities.
To commercialise our drug in Europe
now
wer’e all talking about the FDA
my understanding is if the DMD trial is Stella
we go to the FDA with our Tox study
and possibly we get commercialisation in the US
Can anyone set me straight ?
in other words
if we get the green light in Europe
that’s a Coy maker
remembering Sarepta has none of its 4 drugs approv d in Europe.
Open House 09/SEP/2024, page-33
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.015(13.0%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 12.0¢ | $612.7K | 4.843M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56662 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 600000 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |